Skip to main content

Table 1 Demographic, anthropometric, illness severity and outcome dataa

From: Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

Variable

N = 48

Age, yr

47.3 (17.9)

Male sex, n (%)

27 (56.3)

Height, m

1.70 (0.11)

Weight, kg

88.4 (24.2)

BMI, kg/m2

30.7 (8.78)

BSA, m2

1.98 (0.26)

Admission category/system, n (%)

 
 

Medical

n = 13

  

Cardiac

1 (7.7)

  

Gastrointestinal

3 (23.1)

  

Neurological

2 (15.4)

  

Respiratory

5 (38.5)

  

Primary bacteraemia

1 (7.7)

  

Oncology

1 (7.7)

 

Surgical

n = 13

  

Gastrointestinal

7 (53.8)

  

Gynaecological

1 (7.7)

  

Maxillofacial

2 (15.4)

  

Neurological

2 (15.4)

  

Vascular

1 (7.7)

 

Trauma

n = 22

  

Burns

6 (27.3)

  

Facial

1 (4.5)

  

Abdominal

4 (18.2)

  

Neurological

5 (22.7)

  

Orthopaedic

3 (13.6)

  

Thoracic

3 (13.6)

APACHE II score

19.4 (6.79)

Modified SOFA score, median (IQR)

3.5 (2 to 6)

Mechanical ventilation, n (%)

45 (93.8)

Use of vasopressors, n (%)

12 (25.0)

Presumed/confirmed site of infection, n (%)

 
 

Intraabdominal

14 (29.2)

 

Skin/soft tissue

5 (10.4)

 

Respiratory

24 (50.0)

 

Urinary

1 (2.1)

 

Primary bacteraemia

1 (2.1)

 

Unknown

3 (6.3)

24-hr fluid balance, ml

553 (1836)

Plasma CR, μmol/L

79.5 (31.4)

Measured CLCR, ml/min

122 (59.2)

ICU length of stay, days

18.2 (11.5)

ICU mortality, n (%)

4 (8.3)

Hospital mortality, n (%)

5 (10.4)

  1. aAPACHE, Acute Physiology and Chronic Health Evaluation; BMI, Body mass index; BSA, Body surface area; CLCR, Creatinine clearance; CR, Creatinine; ICU, Intensive care unit; IQR, Interquartile range; SD, Standard deviation; SOFA, Sequential Organ Failure Assessment. Data presented are mean (SD) unless otherwise stated.